Mazor Robotics (MZOR) announced preliminary 3Q17 revenue of US $17.2MM, an increase of more than 225% vs. 3Q16 sales of $7.6MM. Within the quarter, MZOR received 22 system purchase orders from the U.S., Asia and Israel, comprising 19 for Mazor X™ (11 from Medtronic) and 3 for Renaissance from its China distribution partner.
In late 3Q, per agreement terms, Medtronic overtook responsibility for distribution of Mazor X and MZOR transferred a portion of its capital sales team to Medtronic.
Full 3Q17 results are expected by November 7.
Sources: Mazor Robotics Ltd.; ORTHOWORLD Inc.
Mazor Robotics (MZOR) announced preliminary 3Q17 revenue of US $17.2MM, an increase of more than 225% vs. 3Q16 sales of $7.6MM. Within the quarter, MZOR received 22 system purchase orders from the U.S., Asia and Israel, comprising 19 for Mazor X™ (11 from Medtronic) and 3 for Renaissance from its China distribution partner.
In late 3Q, per...
Mazor Robotics (MZOR) announced preliminary 3Q17 revenue of US $17.2MM, an increase of more than 225% vs. 3Q16 sales of $7.6MM. Within the quarter, MZOR received 22 system purchase orders from the U.S., Asia and Israel, comprising 19 for Mazor X™ (11 from Medtronic) and 3 for Renaissance from its China distribution partner.
In late 3Q, per agreement terms, Medtronic overtook responsibility for distribution of Mazor X and MZOR transferred a portion of its capital sales team to Medtronic.
Full 3Q17 results are expected by November 7.
Sources: Mazor Robotics Ltd.; ORTHOWORLD Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





